Trial Runners is Attending the 9th Annual GTC BIO: Ocular Diseases Drug Discovery Conference

Trial Runners is honored to sponsor and attend GTC’s 9th Annual Ocular Disease Drug Discovery Conference in San Diego. Attendance at focused conferences like this one serve several important purposes for Trial Runners:

  • They allow us to stay informed on state-of-the-art technologies and targets in clinical research. This knowledge is critical in maintaining our niche ophthalmology expertise and applying the most accurate and effective methods to your ophthalmology study.
  • They allow us to connect with industry thought leaders to explore ideas and visions in clinical research and share our unique perspective based on years of experience and data.
  • They provide us with the opportunity to connect with potential clients and learn more about how we can advance their initiatives through custom clinical trial management services.


Attendees on behalf of Trial Runners include:

Patrick Healy, Cofounder & Executive Chairman
Darin Curtiss, VP of Clinical Development
Carter Vincent, Director of Strategic Accounts
Megan Greenwood, Director of Strategic Accounts


To meet with a representative of Trial Runners at the 9th Annual Ocular Disease Drug Discovery Conference, contact us at (701) 483-3599 or today. We look forward to connecting to discuss your current or upcoming trials and how Trial Runners may be able to streamline processes and add value.



The 9th Ocular Diseases Drug Discovery Conference is taking place on March 20-21, 2017 in San Diego, CA. We are excited to have top representatives from the industry and academic sectors to discuss technologies and targets that are continually changing the way ocular diseases are treated. Drug delivery is always improving as we look at for better methods to penetrate anterior and poster segments of the eye. Successes in gene therapy and regenerative medicine are proving to be interesting approaches to discuss in detail pre-clinically and clinically. We are gathering leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), dry eye, glaucoma, diabetic macular edema (DME), and other ocular diseases.

See you in San Diego!